EN
抗体药类似物
Research Grade Istiratumab
All
TD-HY353076_1.jpg
  • CatalogTD-HY353076
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsBispecific,MM-005,MM-141,CAS:1509928-04-4
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Istiratumab


Catalog No. TD-HY353076
Species reactivity Human
Applications Research Grade Biosimilar
Host species Human
Isotype IgG1-kappa-[scFv]2
Expression system Mammalian Cells
Clonality Monoclonal
Target CD221, Insulin-like growth factor 1 receptor, IGF1R, Insulin-like growth factor I receptor, IGF-I receptor, ERBB3, HER3, Proto-oncogene-like protein c-ErbB-3, Tyrosine kinase-type cell surface receptor HER3, Receptor tyrosine-protein kinase erbB-3
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P08069 & P21860
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names Bispecific,MM-005,MM-141,CAS:1509928-04-4
Background Istiratumab (M-6495) is bispecific monoclonal antibody targeting IGF-1R and ErbB3. Istiratumab induces IGF-1R and ErbB3 receptor degradation through the proteasome pathway Istiratumab can be used for research of cancers.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HY353076_1.jpg
SDS-PAGE
 
SDS-PAGE for Research Grade Istiratumab.